Have a personal or library account? Click to login
The financial toxicity of breast cancer: a systematic mapping of the literature and identification of research challenges Cover

The financial toxicity of breast cancer: a systematic mapping of the literature and identification of research challenges

Open Access
|Jan 2025

References

  1. Zafar SY. Financial toxicity of cancer care: it’s time to intervene. J Natl Cancer Inst 2016; 108: djv370. doi: 10.1093/jnci/djv370
  2. Lentz R, Benson AB, Kircher S. Financial toxicity in cancer care: prevalence, causes, consequences, and reduction strategies. J Surg Oncol 2019; 120: 85-92. doi: 10.1002/jso.25374
  3. Ehsan AN, Wu CA, Minasian A, Singh T, Bass M, Pace L, et al. Financial toxicity among patients with breast cancer worldwide: a systematic review and meta-analysis. [Internet]. JAMA Netw Open 2023; 6: e2255388. doi: 10.1001/jamanetworkopen.2022.55388. [cited 2024 Mar 15]. Available at: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85147783077&do i=10.1001%2fjamanetworkopen.2022.55388&partnerID=40&md5=c2a725 3b842dc09af15f9af533d51bb2
  4. Azzani M, Atroosh WM, Anbazhagan D, Kumarasamy V, Abdalla MMI. Describing financial toxicity among cancer patients in different income countries: a systematic review and meta-analysis. Front Public Health 2024; 11: 1266533. doi: 10.3389/fpubh.2023.1266533
  5. Longo CJ, Fitch MI, Banfield L, Hanly P, Yabroff KR, Sharp L. Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review. Support Care Cancer 2020; 28: 4645-65. doi: 10.1007/s00520-020-05620-9
  6. Pauge S, Surmann B, Mehlis K, Zueger A, Richter L, Menold N, et al. Patient-reported financial distress in cancer: a systematic review of risk factors in universal healthcare systems. Cancers 2021; 13: 5015. doi: 10.3390/cancers13195015
  7. Smith GL, Lopez-Olivo MA, Advani PG, Ning MS, Geng Y, Giordano SH, et al. Financial burdens of cancer treatment: a systematic review of risk factors and outcomes. J Natl Compr Canc Netw 2019; 17: 1184-92. doi: 10.6004/jnccn.2019.7305
  8. Çelik Y, Çelik SŞ, Sariköse S, Arslan HN. Evaluation of financial toxicity and associated factors in female patients with breast cancer: a systematic review and meta-analysis. Support Care Cancer 2023; 31: 691. doi: 10.1007/s00520-023-08172-w
  9. Verhoeven D, Allemani C, Kaufman C, Mansel R, Siesling S, Anderson B. Breast cancer: global quality care optimizing care delivery with existing financial and personnel resources. ESMO Open [internet] 2019; 4(Suppl 2): e000861. [cited 2024 Mar 21]; Available at: https://www.esmoopen.com/article/S2059-7029(20)32629-6/fulltext
  10. Offodile AC, Asaad M, Boukovalas S, Bailey C, Lin YL, Teshome M, et al. Financial toxicity following surgical treatment for breast cancer: a crosssectional pilot study. Ann Surg Oncol 2021; 28: 2451-62. doi: 10.1245/s10434-020-09216-9
  11. Benedict C, Fisher S, Schapira L, Chao S, Sackeyfio S, Sullivan T, et al. Greater financial toxicity relates to greater distress and worse quality of life among breast and gynecologic cancer survivors. Psychooncology 2022; 31: 9-20. doi: 10.1002/pon.5763
  12. International Agency for Research on Cancer. Cancer today [internet]. 2024 [cited 2024 Mar 21]. Available at: https://gco.iarc.who.int/today/
  13. Cheng H, Lin L, Liu T, Wang S, Zhang Y, Tian L. Financial toxicity of breast cancer over the last 30 years: a bibliometrics study and visualization analysis via CiteSpace. Medicine 2023; 102: e33239. doi: 10.1097/MD.0000000000033239
  14. Elsevier. Scopus. Scopus content [internet]. 2024 [cited 2024 Feb 15]. Available at: https://www.elsevier.com/products/scopus/content
  15. Tuttle B; LibGuides. Database Search Tips. Scopus [internet]. 2023 [cited 2024 Feb 15]. Available at: https://guides.mclibrary.duke.edu/searchtips/scopus
  16. Matthews T. LibGuides: resources for librarians and administrators. Web of Science Coverage Details [internet]. 2024 [cited 2024 Feb 15]. Available at: https://clarivate.libguides.com/librarianresources/coverage
  17. Roblek V, Dimovski V, Mesko M, Peterlin J. Evolution of organisational agility: a bibliometric study. Kybernetes 2022; 51: 119-37. doi: 10.1108/K-11-2021-1137
  18. Aria M, Cuccurullo C. Bibliometrix: an R-tool for comprehensive science mapping analysis. J Informetr 2017; 11: 959-75. doi: 10.1016/j.joi.2017.08.007
  19. Zupic I, Čater T. Bibliometric methods in management and organization. Organizational Research Methods [internet]. 2014 [cited 2020 May 19]. 18: 429-72. doi: 10.1177/1094428114562629. Available at: https://journals.sagepub.com/doi/10.1177/1094428114562629
  20. Perianes-Rodriguez A, Waltman L, van Eck NJ. Constructing bibliometric networks: a comparison between full and fractional counting. J Inform 2016; 10: 1178-95. doi: 10.1016/j.joi.2016.10.006
  21. Bibliometrix. Home [internet]. 2024 [cited 2024 Jan 26]. Available at: https://www.bibliometrix.org/home/index.php
  22. Feinerer I, Hornik K, Meyer D. Text Mining Infrastructure in R [internet]. J Stat Softw 2008 [cited 2017 Feb 2]; 25: 1-54. Available at: http://www.jstatsoft.org/v25/i05/
  23. Feldman R, Dagan I, Hirsh H. Mining text using keyword distributions. J Intell Inf Syst 1998; 10: 281-300. doi: 10.1023/A:1008623632443
  24. Godnov U, Redek T. Application of text mining in tourism: case of Croatia. Ann Tour Res 2016; 58: 162-6. doi: 10.1016/j.annals.2016.02.005
  25. Liu B. Sentiment analysis and opinion mining. San Rafael, Calif.: Morgan & Claypool Publishers; 2012. p. 180.
  26. Benoit K, Watanabe K, Wang H, Nulty P, Obeng A, Müller S, et al. quanteda: an R package for the quantitative analysis of textual data. J Open Source Soft 2018; 3: 774. doi: 10.21105/joss.00774P
  27. Centre for Science and Technology Studies. VOSviewer. Visualizing scientific landscapes [Internet]. VOSviewer 2021 [cited 2021 Mar 7]. Available at: https://www.vosviewer.com//
  28. Arozullah AM, Calhoun EA, Wolf M, Finley DK, Fitzner KA, Heckinger EA, et al. The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol 2004; 2: 271-8. PMID: 15328826
  29. Bradley CJ, Neumark D, Luo Z, Schenk M. Employment and cancer: findings from a longitudinal study of breast and prostate cancer survivors. Cancer Invest 2007; 25: 47-54. 10.1080/07357900601130664
  30. Nash-Stewart CE, Kruesi LM, Del Mar CB. Does Bradford’s law of scattering predict the size of the literature in Cochrane reviews? J Med Libr Assoc 2012; 100: 135-8. doi: 10.3163/1536-5050.100.2.013
  31. Jagsi R, Pottow JAE, Griffith KA, Bradley C, Hamilton AS, Graff J, et al. Longterm financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol 2014; 32: 1269-76. doi: 10.1200/JCO.2013.53.0956
  32. Jagsi R, Ward KC, Abrahamse PH, Wallner LP, Kurian AW, Hamilton AS, et al. Unmet need for clinician engagement regarding financial toxicity after diagnosis of breast cancer. Cancer 2018; 124: 3668-76. doi: 10.1002/cncr.31532
  33. Jagsi R, Hawley ST, Abrahamse P, Li Y, Janz NK, Griggs JJ, et al. Impact of adjuvant chemotherapy on long-term employment of survivors of early-stage breast cancer. Cancer 2014; 120: 1854-62. doi: 10.1002/cncr.28607
  34. Sidey-Gibbons C, Pfob A, Asaad M, Boukovalas S, Lin YL, Selber JC, et al. Development of machine learning algorithms for the prediction of financial toxicity in localized breast cancer following surgical treatment. JCO Clin Cancer Inform 2021; 5: 338-47. doi: 10.1200/CCI.20.00088
  35. Coroneos CJ, Lin YL, Sidey-Gibbons C, Asaad M, Chin B, Boukovalas S, et al. Correlation between financial toxicity, quality of life, and patient satisfaction in an insured population of breast cancer surgical patients: a singleinstitution retrospective study. J Am Coll Surg 2021; 232: 253-63. 10.1016/j.jamcollsurg.2020.10.023
  36. Wheeler SB, Spencer JC, Pinheiro LC, Carey LA, Olshan AF, Reeder-Hayes KE. Financial impact of breast cancer in black versus white women. J Clin Oncol 2018; 36: 1695-701. doi: 10.1200/JCO.2017.77.6310
  37. Greenup RA, Rushing C, Fish L, Campbell BM, Tolnitch L, Hyslop T, et al. Financial costs and burden related to decisions for breast cancer surgery. J Oncol Pract 2019; 15: e666-76. doi: 10.1200/JOP.18.00796
  38. Spencer JC, Rotter JS, Eberth JM, Zahnd WE, Vanderpool RC, Ko LK, et al. Employment changes following breast cancer diagnosis: the effects of race and place. J Natl Cancer Inst 2020; 112: 647-50. doi: 10.1093/jnci/djz197
  39. Bradley CJ, Bednarek HL, Neumark D. Breast cancer survival, work, and earnings. J Health Econ 2002; 21: 757-79. doi: 10.1016/S0167-6296(02)00059-0
  40. Veenstra CM, Wallner LP, Jagsi R, Abrahamse P, Griggs JJ, Bradley CJ, et al. Long-term economic and employment outcomes among partners of women with early-stage breast cancer. J Oncol Pract 2017; 13: e916-26. doi: 10.1200/JOP.2017.023606
  41. Jagsi R, Hawley ST, Abrahamse P, Yun Li, Nancy K Janz, Jennifer J Griggs, et al. Impact of adjuvant chemotherapy on long-term employment of survivors of early-stage breast cancer. Cancer 2014; 120: 1854-62. doi: 10.1002/cncr.28607
  42. Bensman SJ, Smolinsky LJ. Lotka’s inverse square law of scientific productivity: its methods and statistics [Internet]. arXiv 1601.04950; 2016 [cited 2024 Feb 18]. Available at: http://arxiv.org/abs/1601.04950
  43. Costas R, Bordons M. The h-index: advantages, limitations and its relation with other bibliometric indicators at the micro level. J Inform 2007; 1: 193-203. doi: 10.1016/j.joi.2007.02.001
  44. Lauzier S, Maunsell E, Drolet M, Coyle D, Hébert-Croteau N, Brisson J, et al. Wage losses in the year after breast cancer: extent and determinants among Canadian women. J Natl Cancer Instit 2008; 100: 321-32. doi: 10.1093/jnci/djn028.
  45. Gordon L, Scuffham P, Hayes S, Newman B. Exploring the economic impact of breast cancers during the 18 months following diagnosis. Psychooncology 2007; 16: 1130-9. doi: 10.1002/pon.1182
  46. Meneses K, Azuero A, Hassey L, McNees P, Pisu M. Does economic burden influence quality of life in breast cancer survivors? Gynecol Oncol 2012; 124: 437-43. doi: 10.1016/j.ygyno.2011.11.038
  47. Zha H. Generic summarization and keyphrase extraction using mutual reinforcement principle and sentence clustering [internet]. 2002. [cited 2024 Mar 16]. Available at: https://citeseerx.ist.psu.edu/document?repid=rep1& type=pdf&doi=42e0376c29ad9510464b7a643a49cfc3b60c2cad
  48. Montero AJ, Eapen S, Gorin B, Adler P. The economic burden of metastatic breast cancer: a U.S. managed care perspective. Breast Cancer Res Treat 2012; 134: 815-22. doi: 10.1007/s10549-012-2097-2
  49. Max W, Sung HY, Stark B. The economic burden of breast cancer in California. Breast Cancer Res Treat 2009; 116: 201-7. doi: 10.1007/s10549-008-0149-4
  50. Wadasadawala T, Sen S, Watekar R, Rane P, Sarin R, Gupta S, et al. Economic distress of breast cancer patients seeking treatment at a tertiary cancer center in Mumbai during COVID-19 pandemic: a cohort study. Asian Pac J Cancer Prev 2021; 22: 793-800. doi: 10.31557/APJCP.2021.22.3.793
  51. Chapman B, Swainston J, Grunfeld EA, Derakshan N. COVID-19 outbreak effects on job security and emotional functioning amongst women living with breast cancer. Front Psychol 2020; 11: 582014. doi: 10.3389/fpsyg.2020.582014
  52. Boyages J, Xu Y, Kalfa S, Koelmeyer L, Parkinson B, Mackie H, et al. Financial cost of lymphedema borne by women with breast cancer. Psychooncology 2017; 26: 849-55. doi: 10.1002/pon.4239
  53. Foster TS, Miller JD, Boye ME, Blieden MB, Gidwani R, Russell MW. The economic burden of metastatic breast cancer: a systematic review of literature from developed countries. Cancer Treat Rev 2011; 37: 405-15. doi: 10.1016/j.ctrv.2010.12.008
  54. Lamerato L, Havstad S, Gandhi S, Jones D, Nathanson D. Economic burden associated with breast cancer recurrence: findings from a retrospective analysis of health system data. Cancer 2006; 106: 1875-82. doi: 10.1002/cncr.21824
  55. Jing J, Feng R, Zhang X, Li M, Gao J. Financial toxicity and its associated patient and cancer factors among women with breast cancer: a single-center analysis of low-middle income region in China. Breast Cancer Res Treat 2020; 181: 435-43. doi: 10.1007/s10549-020-05632-3
  56. Ruan J, Liu C, Yang Z, Kuang Y, Yuan X, Qiu J, et al. Suffering and adjustment: a grounded theory of the process of coping with financial toxicity among young women with breast cancer. Support Care Cancer 2024; 32: 96. doi: 10.1007/s00520-024-08305-9
  57. Rumrill PD, Nutter DL, Hennessey M, Ware ME. Job retention and breast cancer: employee perspectives and implications for rehabilitation planning. Work 1998; 10: 251-9. doi: 10.3233/WOR-1998-10306
  58. Monteiro I, Morais S, Costa AR, Lopes-Conceição L, Araújo N, Fontes F, Dias T, Pereira S, Lunet N. Changes in employment status up to 5 years after breast cancer diagnosis: a prospective cohort study. Breast 2019; 48: 38-44. doi: 10.1016/j.breast.2019.07.007
  59. Witte J, Mehlis K, Surmann B, Lingnau R, Damm O, Greiner W, et al. Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications. Ann Oncol 2019; 30: 1061-70. doi: 10.1093/annonc/mdz140
  60. Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, et al. The financial toxicity of cancer treatment: a pilot study assessing out-ofpocket expenses and the insured cancer patient’s experience. Oncologist 2013; 18: 381-90. doi: 10.1634/theoncologist
  61. Vaalavuo M. The unequal impact of ill health: earnings, employment, and mental health among breast cancer survivors in Finland [Internet]. Labour Econ 2021 [cited 2024 Mar 17]; 69: 101967. doi: 10.1016/j.la-beco.2021.101967. Available at: https://www.scopus.com/inward/record. uri?eid=2-s2.0-85100212299&doi=10.1016%2fj.labeco.2021.101967&part nerID=40&md5=0676064fbcadefe09abdd1671fda55d0
  62. Gilligan AM, Alberts DS, Roe DJ, Skrepnek GH. Death or debt? National estimates of financial toxicity in persons with newly-diagnosed cancer. Am J Med 2018; 131: 1187-99.e5. doi: 10.1016/j.amjmed.2018.05.020
  63. Ng AP, Sanaiha Y, Verma A, Lee C, Akhavan A, Cohen JG, et al. Insurancebased disparities and risk of financial toxicity among patients undergoing gynecologic cancer operations. Gynecol Oncol 2022; 166: 200-6. doi: 10.1016/j.ygyno.2022.05.017
  64. Chan R, Cooper B, Paul S, Conley Y, Kober K, Koczwara B, et al. Distinct financial distress profiles in patients with breast cancer prior to and for 12 months following surgery. BMJ Support Palliat Care 2022; 12: 347-354. doi: 10.1136/bmjspcare-2020-002461
  65. Chan RJ, Cooper B, Gordon L, Hart N, Tan CJ, Koczwara B, et al. Distinct employment interference profiles in patients with breast cancer prior to and for 12 months following surgery. BMC Cancer 2021; 21: 883. doi: 10.1186/s12885-021-08583-0
  66. Chan RJ, Cooper B, Koczwara B, Chan A, Tan CJ, Paul SM, et al. A longitudinal analysis of phenotypic and symptom characteristics associated with interindividual variability in employment interference in patients with breast cancer. Support Care Cancer 2020; 28: 4677-86. doi: 10.1007/s00520-020-05312-4
  67. Chan RJ, Cooper B, Koczwara B, Chan A, Tan CJ, Gordon L, et al. Characteristics associated with inter-individual variability in financial distress in patients with breast cancer prior to and for 12 months following surgery. Support Care Cancer 2022; 30: 1293-302. doi: 10.1007/s00520-021-06524-y
  68. Mollica MA, Zaleta AK, Gallicchio L, Brick R, Jacobsen PB, Tonorezos E, et al. Financial toxicity among people with metastatic cancer: findings from the Cancer Experience Registry. Support Care Cancer 2024; 32: 137. doi: 10.1007/s00520-024-08328-2
  69. Ribi K, Pagan E, Sala I, Ruggeri M, Bianco N, Bucci EO, et al. Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland. J Cancer Surviv 2023; 17: 1847-58. doi: 10.1007/s11764-022-01222-y
  70. Dumas A, Luis IV, Bovagnet T, El Mouhebb M, Di Meglio A, Pinto S, et al. Impact of breast cancer treatment on employment: results of a multicenter prospective cohort study (CANTO). J Clin Oncol 2020; 38: 734-43. doi: 10.1200/JCO.19.01726
  71. Foster TS, Miller JD, Boye ME, Blieden MB, Gidwani R, Russell MW. The economic burden of metastatic breast cancer: a systematic review of literature from developed countries. Cancer Treat Rev 2011; 37: 405-15. doi: 10.1016/j.ctrv.2010.12.008
  72. Kuper H, Yang L, Theorell T, Weiderpass E. Job strain and risk of breast cancer. Epidemiology 2007; 18: 764-8. doi: 10.1097/EDE.0b013e318142c534
  73. Desai A, Gyawali B. Financial toxicity of cancer treatment: moving the discussion from acknowledgement of the problem to identifying solutions. eClinicalMedicine [Internet]. 2020 [cited 2024 Mar 21]; 20: 100269. doi: 10.1016/j.eclinm.2020.100269. Available at: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30013-4/fulltext
  74. Winkler EC, Mehlis K, Surmann B, Witte J, Lingnau R, Apostolidis L, et al. Financial toxicity in German cancer patients: how does a chronic disease impact the economic situation? 43rd ESMO Congress (ESMO). Ann Oncol 2018; 29(Suppl 8): 568. doi: 10.1093/annonc/mdy424.079
  75. Witte J, Mehlis K, Surmann B, Lingnau R, Damm O, Greiner W, et al. Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications. Ann Oncol 2019; 30: 1061-70. doi: 10.1093/annonc/mdz140
  76. Cheng H, Lin L, Liu T, Wang S, Zhang Y, Tian L. Financial toxicity of breast cancer over the last 30 years: a bibliometrics study and visualization analysis via CiteSpace. Medicine 2023; 102: e33239. doi: 10.1097/MD.0000000000033239
  77. Donthu N, Kumar S, Mukherjee D, Pandey N, Lim WM. How to conduct a bibliometric analysis: an overview and guidelines. J Bus Res 2021; 133: 285-96. doi: 10.1016/j.jbusres.2021.04.070
  78. FACIT.org. FACIT-COST. COST: a FACIT measure of financial toxicity [Internet]. FACIT Group. 2024 [cited 2024 Mar 21]. Available at: https://www.facit.org/measures/facit-cost
DOI: https://doi.org/10.2478/raon-2025-0002 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 31 - 42
Submitted on: Apr 3, 2024
|
Accepted on: Aug 16, 2024
|
Published on: Jan 4, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Ivica Ratosa, Mojca Bavdaz, Petra Dosenovic Bonca, Helena Barbara Zobec Logar, Andraz Perhavec, Marjeta Skubic, Katja Vörös, Ana Mihor, Vesna Zadnik, Tjasa Redek, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.